Your browser doesn't support javascript.
loading
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
González, Luis Alonso; Alarcón, Graciela S; Harvey, Guillermina B; Quintana, Rosana; Pons-Estel, Guillermo J; Ugarte-Gil, Manuel F; Vásquez, Gloria; Catoggio, Luis J; García, Mercedes A; Borba, Eduardo F; Da Silva, Nilzio A; Tavares Brenol, João C; Toledano, Marlene Guibert; Massardo, Loreto; Neira, Oscar; Pascual-Ramos, Virginia; Amigo, Mary-Carmen; Barile-Fabris, Leonor A; De La Torre, Ignacio García; Alfaro-Lozano, José; Segami, María I; Chacón-Díaz, Rosa; Esteva-Spinetti, María H; Iglesias-Gamarra, Antonio; Pons-Estel, Bernardo A.
Afiliação
  • González LA; División de Reumatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
  • Alarcón GS; Division of Clinical Immunology and Rheumatology, Department of Medicine, Marnix E. Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Harvey GB; Department of Medicine, School of Medicine, Universidad Peruana Cayetano, Heredia, Lima, Perú.
  • Quintana R; Escuela de Estadística, Facultad de Ciencias Económicas y Estadística, Universidad Nacional de Rosario, Rosario, Argentina.
  • Pons-Estel GJ; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Ugarte-Gil MF; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Vásquez G; Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú.
  • Catoggio LJ; Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Perú.
  • García MA; División de Reumatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
  • Borba EF; Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Da Silva NA; Servicio de Reumatología, HIGA San Martin de La Plata, Buenos Aires, Argentina.
  • Tavares Brenol JC; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Toledano MG; Rheumatology Unit, Faculdade de Medicina da Universidad e Federal de Goias, Goiania, Brazil.
  • Massardo L; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Neira O; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Pascual-Ramos V; Servicio Nacional de Reumatología, Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba.
  • Amigo MC; Centro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago de Chile, Chile.
  • Barile-Fabris LA; Sección de Reumatología, Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • De La Torre IG; Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, México.
  • Alfaro-Lozano J; Reumatología, Centro Médico ABC, Ciudad de México, México.
  • Segami MI; Hospital Ángeles del Pedregal, Ciudad de México, México.
  • Chacón-Díaz R; Departamento de Inmunología y Reumatología, Hospital General de Occidentede la S.S. y Universidad de Guadalajara, Zapopan, Jalisco, México.
  • Esteva-Spinetti MH; Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú.
  • Iglesias-Gamarra A; Hospital Nacional "Edgardo Rebagliati Martins", Essalud, Lima, Perú.
  • Pons-Estel BA; Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Caracas, Venezuela.
Lupus ; 32(5): 658-667, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36916674
ABSTRACT

OBJECTIVE:

To determine the predictors of the occurrence of severe autoimmune hemolytic anemia (AIHA) and its impact on damage accrual and mortality in SLE patients.

METHODS:

Factors associated with time to severe AIHA (hemoglobin level ≤7 g/dL) occurring from the onset of SLE symptoms were examined by Cox proportional hazards regressions. The association of severe AIHA with mortality was examined by logistic regression analyses while its impact on damage was by negative binomial regression.

RESULTS:

Of 1,349 patients, 49 (3.6%) developed severe AIHA over a mean (SD) follow-up time of 5.4 (3.8) years. The median time from the first clinical manifestation to severe AIHA was 111 days (IQR 43-450). By multivariable analysis, male sex (HR 2.26, 95% CI 1.02-4.75, p = 0.044), and higher disease activity at diagnosis (HR 1.04, 95% CI 1.01-1.08, p = 0.025) were associated with a shorter time to severe AIHA occurrence. Of the SLEDAI descriptors, only hematologic (leukopenia and/or thrombocytopenia) showed a certain trend toward significance in the multivariable analysis (HR 2.36, 95% CI 0.91-6.13, p = 0.0772). Severe AIHA contributed neither to damage nor to mortality.

CONCLUSIONS:

Severe AIHA occurs during the early course of SLE. Male sex and higher disease activity at diagnosis emerged as independent predictors of a shorter time to severe AIHA occurrence. Although not statistically significant, hematological abnormalities at SLE diagnosis could predict the occurrence of severe AIHA in a shorter time. Damage and mortality did not seem to be impacted by the occurrence of severe AIHA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Anemia Hemolítica Autoimune / Leucopenia / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Anemia Hemolítica Autoimune / Leucopenia / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article